RM
Rakuten Medical
United States · Biotech
Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series F | $100M | ABIES Capital — Role not disclosedDaiwa Securities — Role not disclosedMickey Mikitani — Role not disclosedMitsui Sumitomo Insurance — Role not disclosedNexus CVC — Role not disclosedOEP Group — Role not disclosedRakuten Group — Role not disclosedSBI Group — Role not disclosedSumitomo Mitsui Banking — Role not disclosedTaiAx Life Science Fund — Role not disclosed |